Plant-Based chondroitin puts joint health to the test
NCT ID NCT07727174
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This study investigates whether chondroitin sulfate from two sources—fermentation (MyCondro™) and bovine (cow)—can influence the health of cartilage, joint capsule, and bone cells. Ten healthy men will take each supplement, and their blood will be tested on human cells in the lab to measure effects on cell growth, metabolism, and inflammation. The goal is to understand how these supplements might support joint health at a cellular level.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- chondroitin sulfate from fermentation (MyCondro™) and bovine chondroitin sulfate
- What this could lead to
- If the study shows biological activity, it could support developing plant-based chondroitin supplements for joint health.
- What could go wrong
- This is a very small, early-stage study in healthy men, not people with joint problems. Results may not translate to real-world benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 10 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 35 years
- Sex
-
Male participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Men. * 18-35 years old (terminals included). * Liver test in the reference standards. * Renal assessment in the reference standards. * NFS in the reference standards. * CRP in the reference standards. * Blood pressure compatible with the conduct of the study. * Non-smoker or occasional smoker (\<5 cigarettes/day or \< 10ml per week of electronic cigarette liquid dosed at 3 mg/ml of nicotine). * \< to 5 hours of intense sport per week. * Weight≥ to 60 kg. * BMI between 20 and 28 kg/m² (terminals not included). * Subjects able and willing to comply with the protocol and provide written informed consent. * Subjects affiliated to social security Exclusion Criteria: * All types of vaccination under one month. * Alcohol consumption above WHO standards (\>3 glasses of alcohol per day for men). * Ongoing treatment (medication, dietary supplement or probiotic) and within 4 weeks prior to inclusion. * Known pathology (including seasonal). * Allergy to the study product (all types) * People with a diet that is not suitable for the conduct of the study (e.g. vegetarian, vegan or vegan diet). * Change in eating habits in the 4 weeks prior to inclusion. * Medical and/or surgical history judged by the investigator or his/her representative to be incompatible with the trial. * Blood donation made in the 3 months prior to the inclusion visit or intending to do so during the study. * Persons under guardianship, curatorship, deprivation of liberty, safeguard of justice. * Refusal to sign the information sheet and consent. * Refusal to be registered on the National Register of Volunteers who lend themselves to research involving the human person. * Person who is excluded from another study on the national volunteer database, or who has received more than €6000 in the year following their participation in clinical studies.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Joint health are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Centre d'investigation clinique | CIC
Clermont-Ferrand, Cedex 1, 63003, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.